Orion Pharma

Focus: Orion Pharma is a UK-based pharmaceutical company specializing in small molecules and generics, with a concentrated portfolio heavily dependent on Parkinson's disease treatments. The company operates in neurology with a legacy focus on the STALEVO franchise.

Neurology

Profile data last refreshed 14h ago · AI intelligence enriched 1mo ago

Open Jobs

About Orion Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow Orion Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Generated by Claude from Orion Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

STALEVO 100

Parkinson's Disease

$229K

LOE Approaching

Flagship product representing 36% of company revenue; approaching loss of exclusivity with no disclosed LOE date.

Help build intelligence for Orion Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Sham

Degenerative Lumbar Spinal Stenosis

N/A

Clinical Trials (1)

NCT06532968Clinical Evaluation of Orion Lamina Cover in Patients Undergoing Lumbar Laminectomy With Instrumented Fusion

N/A

Remo-Wax® Oil

Itching

N/A

Clinical Trials (1)

NCT05811039Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal

N/A

Vitamin D 100ug

Chronic Pancreatitis

N/A

Clinical Trials (1)

NCT02965898The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis

N/A

Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advan

Prostate Cancer

N/A

Clinical Trials (1)

NCT01574846Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer

N/A

SOC

Critical Illness

N/A

Clinical Trials (1)

NCT01707680Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care Patients

N/A

Levosimendan

Respiratory Muscle Function

N/A

Clinical Trials (1)

NCT01101620Effect of Levosimendan on Respiratory Muscle Function in Healthy Subjects

N/A

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

Asthma

N/A

Clinical Trials (1)

NCT03755544Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

N/A

Levosimendan Pharmacokinetics in Children

Acute Heart Failure

N/A

Clinical Trials (1)

NCT01704131Levosimendan Pharmacokinetics in Children

N/A

Remo-Wax

Cerumen Impaction of Both Ears

N/A

Clinical Trials (1)

NCT03802903Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax

N/A

Budesonide-Formoterol

Asthma

N/A

Clinical Trials (1)

NCT04663386Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway

N/A

Levosimendan

Ventricular Dysfunction, Left

N/A

Clinical Trials (1)

NCT02972918Preoperative levosimendán and Hip Fracture

N/A

NIOX MINO

Asthma

N/A

Clinical Trials (1)

NCT01783132Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

N/A

Subsyndromal Delirium in Intensive Care Unit

Delirium

N/A

Clinical Trials (1)

NCT03813459Subsyndromal Delirium in Intensive Care Unit

N/A

Placebo Tiotropium inhalation powder type A

Healthy Volunteer

N/A

Clinical Trials (1)

NCT04147572Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler

N/A

Budesonide Easyhaler

Asthma

N/A

Clinical Trials (1)

NCT02048930Real Life Effectiveness of Easyhaler (Orion)

N/A

Budesonide

Healthy

N/A

Clinical Trials (1)

NCT01457716Pharmacokinetic Pilot Study on Budesonide/Formoterol

N/A

DTx for pain software

Chronic Low Back Pain

N/A

Clinical Trials (1)

NCT04225884Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic Pain

N/A

Easyhaler type A

Asthma

N/A

Clinical Trials (1)

NCT01424137Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

N/A

Empty inhalers

Asthma

N/A

Clinical Trials (1)

NCT00984906Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers

N/A

HIT exercise intervention

Type 2 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT01344928The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes

N/A

Low normal PaCO2

Out-of-Hospital Cardiac Arrest

N/A

Clinical Trials (1)

NCT02698917Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation

N/A

18F Fluoroestradiol Radiopharmaceutical with PET/CT

Metastatic Breast Cancer

N/A

Clinical Trials (1)

NCT05068726Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

N/A

GBS-NN/NN2

Group B Streptococcus Infection

N/A

ORM-14540

Healthy

Phase 1

Clinical Trials (1)

NCT00831077Early Phase I Microdosing Study of ORM-14540 and ORM-12741

Phase 1

ORM-12741

Healthy Male Volunteers

Phase 1

Clinical Trials (1)

NCT00817544Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741

Phase 1

ORM-12741

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT00818740Pharmacokinetic Study of ORM-12741 in Healthy Volunteers

Phase 1

ORM-12741 MR A

Healthy

Phase 1

Clinical Trials (1)

NCT02303860Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)

Phase 1

ODM-104

Healthy

Phase 1

Clinical Trials (1)

NCT01840423Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers

Phase 1

BAY1841788

Biological Availability

Phase 1

Clinical Trials (1)

NCT03048110Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

Phase 1

ORM-12741

Healthy

Phase 1

Clinical Trials (1)

NCT00829907A PET Study With ORM-12741

Phase 1

ODM-104

CNS Disease

Phase 1

Clinical Trials (1)

NCT04571996Blood-Brain Barrier Penetration of Therapeutic Agents in Human

Phase 1

BAY1841788

Pharmacokinetics

Phase 1

Clinical Trials (1)

NCT02894385Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Phase 1

ODM 203

Solid Tumours

Phase 1

Clinical Trials (1)

NCT02264418Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours

Phase 1

ORM-12741

Healthy

Phase 1

Clinical Trials (1)

NCT00792493Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

Phase 1

OB-002

Metastatic Cancer

Phase 1

Clinical Trials (1)

NCT05940844Study of OB-002 in Patients With Refractory Metastatic Cancer

Phase 1

ORM-12741

Healthy Volunteer

Phase 1

Clinical Trials (1)

NCT03440021Single-dose Novel Selective alpha2c Antagonist Pharmaco-MRI Study in Healthy Volunteers

Phase 1

ODM-203

Healthy

Phase 1

Clinical Trials (1)

NCT03240445Impact of Changing the Dosing Regimen on the PK Profile of ODM-203

Phase 1

Levodopa, carbidopa, ODM-104

Parkinson Disease

Phase 1

Clinical Trials (1)

NCT03140956Pharmacokinetic of Levodopa Study in Healthy Males

Phase 1

Dabigatran etexilate

Prostatic Neoplasms

Phase 1

Clinical Trials (1)

NCT03237416Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers

Phase 1

PnuBioVax

Pneumococcal Infection

Phase 1

Clinical Trials (1)

NCT02572635A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax

Phase 1

ODM-106

Healthy Volunteer Study

Phase 1

Clinical Trials (1)

NCT02393950Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers